Point72 Asset Management’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-1,213,576
| Closed | -$9.47M | – | 3837 |
|
|
2025
Q4 | $9.47M | Buy |
1,213,576
+975,389
| +410% | +$7.05M | 0.01% | 1391 |
|
|
2025
Q3 | $1.81M | Buy |
+238,187
| New | +$1.98M | ﹤0.01% | 1480 |
|
|
2024
Q2 | – | Sell |
-1,616,244
| Closed | -$8.21M | – | 1877 |
|
|
2024
Q1 | $8.21M | Buy |
+1,616,244
| New | +$9.09M | 0.02% | 787 |
|
|
2023
Q4 | – | Sell |
-2,758,813
| Closed | -$19.5M | – | 2186 |
|
|
2023
Q3 | $19.5M | Sell |
2,758,813
-1,245,887
| -31% | -$8.95M | 0.07% | 412 |
|
|
2023
Q2 | $28.2M | Buy |
4,004,700
+3,951,200
| +7,385% | +$31.7M | 0.1% | 292 |
|
|
2023
Q1 | $446K | Sell |
53,500
-1,935,127
| -97% | -$18.6M | ﹤0.01% | 1264 |
|
|
2022
Q4 | $22.8M | Buy |
+1,988,627
| New | +$24.8M | 0.09% | 310 |
|
|
2022
Q3 | – | Sell |
-644,100
| Closed | -$6.82M | – | 1418 |
|
|
2022
Q2 | $6.82M | Buy |
+644,100
| New | +$6.64M | 0.03% | 620 |
|
|
2022
Q1 | – | Sell |
-25,272
| Closed | -$350K | – | 1180 |
|
|
2021
Q4 | $350K | Sell |
25,272
-178,641
| -88% | -$2.36M | ﹤0.01% | 984 |
|
|
2021
Q3 | $2.93M | Buy |
+203,913
| New | +$3.22M | 0.01% | 746 |
|
|
2021
Q1 | – | Sell |
-3,230,800
| Closed | -$24.1M | – | 964 |
|
|
2020
Q4 | $24.1M | Buy |
3,230,800
+2,598,200
| +411% | +$13.4M | 0.13% | 240 |
|
|
2020
Q3 | $2.17M | Sell |
632,600
-254,970
| -29% | -$1.09M | 0.01% | 699 |
|
|
2020
Q2 | $4.23M | Sell |
887,570
-2,130,562
| -71% | -$8.51M | 0.03% | 502 |
|
|
2020
Q1 | $6.04M | Sell |
3,018,132
-5,364,768
| -64% | -$14.8M | 0.05% | 361 |
|
|
2019
Q4 | $28.9M | Buy |
8,382,900
+5,122,900
| +157% | +$12.9M | 0.16% | 192 |
|
|
2019
Q3 | $9.34M | Buy |
+3,260,000
| New | +$10.1M | 0.06% | 369 |
|
|
2019
Q2 | – | Sell |
-47,453
| Closed | -$386K | – | 1338 |
|
|
2019
Q1 | $386K | Sell |
47,453
-302,547
| -86% | -$2.59M | ﹤0.01% | 891 |
|
|
2018
Q4 | $2.83M | Buy |
+350,000
| New | +$2.72M | 0.02% | 666 |
|
|
2018
Q1 | – | Sell |
-933,766
| Closed | -$4.58M | – | 948 |
|
|
2017
Q4 | $4.58M | Buy |
+933,766
| New | +$4.52M | 0.02% | 608 |
|
|
2015
Q3 | – | Sell |
-2,000
| Closed | -$30K | – | 765 |
|
|
2015
Q2 | $30K | Buy |
+2,000
| New | +$22.7K | ﹤0.01% | 695 |
|
Other funds holding BCRX
RCM
DM
VPM
VCM
TCM
PA
VPC